ALKERMES | ALKS - Azione





Azione Cambiamento Data
AbbVie USD 5.31B 178M 2026-09
Acadia Pharmaceuticals USD 40.36M 68.31M 2026-09
ALKERMES USD 261.1M 37.86M 2026-09
Amgen USD 6.39B 169M 2026-09
Biogen USD 2.22B 159.9M 2026-09
BioMarin Pharmaceutical USD 1.8B 13.54M 2026-09
Bristol-Myers Squibb USD 2.7B 33M 2026-09
Coherus Biosciences USD 5.67M 842K 2026-06
Eli Lilly USD 18.19B 1.4B 2026-09
Gilead Sciences USD 1.9B 57M 2026-09
Heron Therapeutics USD 54.57M 2.33M 2022-12
Ionis Pharmaceuticals USD 28.58M 22.26M 2026-09
J&J USD 15.38B 233M 2026-09
Merck USD 6.16B 43M 2026-09
Nektar Therapeutics USD 14.46M 1.78M 2024-06
Neurocrine Biosciences USD 66.1M 38.1M 2026-09
Otsuka Holdings JPY 413.83B 82M 2026-09
Pfizer USD 10.02B 77M 2026-09
Regeneron Pharmaceuticals USD 2.89B 189.7M 2026-09
Vertex Pharmaceuticals USD 2.25B 480.2M 2026-09